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Genetic background aﬀects susceptibility to ileocolitis in mice deﬁcient in two intracellular glutathione peroxidases, GPx1 and
GPx2. The C57BL/6 (B6) GPx1/2 double-knockout (DKO) mice have mild ileocolitis, and 129S1/Sv (129) DKO mice have severe
inﬂammation. We used diet to modulate ileocolitis; a casein-based deﬁned diet with AIN76A micronutrients (AIN) attenuates
inﬂammation compared to conventional LabDiets. Because luminal microbiota induce DKO ileocolitis, we assessed bacterial
composition with automated ribosomal intergenic-spacer analysis (ARISA) on cecal DNA. We found that mouse strain had the
strongest impact on the composition of microbiota than diet and GPx genotypes. In comparing AIN and LabDiet, DKO mice were
more resistant to change than the non-DKO or WT mice. However, supplementing yeast and inulin to AIN diet greatly altered
microﬂora proﬁles in the DKO mice. From 129 DKO strictly, we found overgrowth of Escherichia coli. We conclude that genetic
background predisposes mice to colonization of potentially pathogenic E. coli.
1.Introduction
Gut microbiota play an important role in several diseases
including inﬂammatory bowel disease (IBD), type-1 dia-
betes, and obesity [1]. Recent metagenomic studies of the
gut microbiota have shown that bacteria dominate the gut
ecosystem [2]. Between 90 and 98% of bacteria, sampled
either from gut-surface-adherent population or feces, belong
to four bacterial phyla Firmicutes, Bacteroidetes, Proteobac-
teria, and Actinobacteria [3, 4]. Although there is a large
variation in bacterial population in diﬀerent individuals,
the same bacterial phyla predominate in the stomach, small
intestine, colon, and feces from the same individual [2, 5].
However, some IBD patient guts have decreased bacterial
diversity with depletion of members of Firmicutes and
Bacteroidetes [3, 4]. Since understanding gut microbiota may
provide insight for IBD risk, pathogenesis, and treatment
strategies, there is surprisingly little information on the
microbiota information in mouse models of IBD.
While the metagenomic sequencing study on human
fecal microbial genes has expanded the database of bacterial
genomes deposited in the GenBank, the ﬁndings on the
gut microbiota composition also conﬁrm the results from
methodsbasedonbacterial16SribosomalRNA(rRNA)gene
sequences [3–5]. Other noncultured PCR-based methods
have been used to appraise gut microbial composition;
theseincludeautomatedribosomalintergenicspaceranalysis
(ARISA) and terminal restriction fragment length polymor-
phisms [6, 7]. ARISA utilizes conserved 16S and 23S rRNA
gene sequences coupled with variability in the length of the
intergenic spacer to discriminate among bacterial species.
The PCR products are separated by an automated capillary
electrophoresis system with single-nucleotide resolution and
detected by a sensitive laser beam to produce an electro-
pherogram.
ARISA has been used as a crude microbe assay. Metage-
nomic study has estimated that each individual harbors
at least 160 bacterial species and entire cohort harbors
between 1,000 and 1,150 prevalent bacterial species [4]. A
single ARISA primer set on fecal samples only yields 20–
30 consensus products and 100 across all subjects [7–9].
Nevertheless, because ARISA generates a highly reproducible2 International Journal of Inﬂammation
microbiota proﬁle with conventional instrumentation, we
applied this method to assess cecal microbiota in a mouse
IBD model.
We have generated a mouse IBD model by disruption
of two genes encoding for two intracellular glutathione
peroxidases, GPx1 and GPx2 [10, 11]. These GPx1/2-double
knockout (DKO) mice (on a mixed C57BL/6 and 129S1/Sv
genetic background) have microﬂora-dependent ileocolitis,
since germ-free mice do not have inﬂammation [11]. Similar
to other mouse IBD models, genetic background has a
profound eﬀect on disease severity in GPx1/2-DKO mice.
B6 DKO mice have mild ileocolitis, the mixed-strain B6;
1 2 9D K Om i c eh a v em o r es e v e r ed i s e a s e[ 12], and 129DKO
mice have the most severe inﬂammation (from this study).
Since B6 and 129 strains may have diﬀerent innate immune
responses, which can modulate microﬂora community [2,
13], we hypothesized that these two strains of mice also have
diﬀerent gut microbiota.
In addition to genetics, diet also can modulate IBD.
Patients with Crohn’s disease (CD) can be managed by
prescribed diets, which are almost as eﬃcacious as anti-
inﬂammatory corticosteroids [14–16]. For pediatric CD
patients, the enteral nutrition is preferred to corticosteroids
to avoid adverse eﬀects in European countries [17]. The
major impact of enteral nutrition may rely on changes in gut
microbiota [16]. Thus, we also tested whether diet impacts
on the ileocolitis and microﬂora in the DKO mice.
In this manuscript, we analyzed the dietary eﬀect on
mouse IBD on both B6 and 129 genetic backgrounds. Based
on the current knowledge on gut microbiota in IBD patients,
we tested whether mouse genetic background, inﬂammation
(DKO genotype), and diet aﬀected gut microbiota.
2.MaterialsandMethods
2.1. Mice and Diets. Generation of GPx1/2-DKO mice
on the C57BL/6J (B6) × 129S1/SvimJ (129) background
(B6;129) was described previously [10]. B6 colony was
obtained after backcrossing B6;129 mice to B6 for 8
generations. N5 and N10 129 colonies were from B6;129
mice backcrossing to 129 strain for 5 and 10 generations,
respectively. Mice were fed either commercial chows (Lab-
Diet, Richmond, IN) or casein-based deﬁned diets with
AIN76A micronutrients (AIN; Harland-Teklad, Madison,
WI) (Table 1). As speciﬁed in the experiments, some AIN
diets were supplemented with brewers’ yeast or inulin
(Oliggo-Fiber Inulin, a gift from Cargill Inc., Minneapolis,
MN).
When on commercial chows, breeders were maintained
on a high-fat LabDiet, and pups weaned to a low-fat LabDiet
at 22 days of age. When on AIN diets, breeders had 10% corn
oil (CO) and pups had 5% CO. Morbidity describes wasting
mice, which were likely to die in the next 24–48 hours, or
with poor health indicated by low body weight, no weight
gain and diarrhea, and unlikely to recover. When describing
diet eﬀects on the pups before weaning, the diet refers to the
breeder diet. All experiments performed on these mice were
approved by City of Hope IUCUC.
2.2. Histology. Distal ileum and the entire colon were
processed for histopathology analysis. Tissues were scored
for inﬂammation and pathology in a blinded fashion using a
14-point system described previously [11]. Scoring includes
lymphocytes and neutrophils inﬁltration (0–3 points), ileal
Paneth cell or colonic goblet cell degranulation (0–2
points), epithelium reactivity, including crypt distortion
(0–3 points), inﬂammatory foci (0–3 points), and apoptotic
ﬁgures (0–3 points). The threshold for inﬂammation corre-
sponds to a score of 6–7 [18].
2.3. Microbiota Census with Noncultured ARISA and Culture
Methods. Cecal microﬂora were characterized in 22-day-
old pups or younger (16- to 21-day-old) sick mice when
morbidity criteria dictated.
For noncultured ARISA, DNA was isolated from mouse
cecal contents in 1mL TE buﬀer (10mM Tris-HCl, 1mM
EDTA, pH 8.0), 0.15mL phenol, and 0.2g of 1mm Zirco-
nia/Silica beads (BioSpec Products, Inc., Bartlesville, OK)
using a minibead-beater (BioSpec Products, Inc.) [19].
Approximately 150–300μg DNA was extracted from the
cecal contents of each mouse. The ribosomal integenic DNA
was ampliﬁed by PCR using a primer set of ITSF (5 -
GTCGTAACAAGGTAGCCGTA-3 ) and ITSReub (Hex-5 -
GCCAAGGCATCCACC-3 )a sd e s c r i b e d[ 6]. The Hex-
tagged ﬂuorescent reverse primer is used to identify the
products on the DNA sequencing instrument. One μL
of 25μL reaction mixture was analyzed with a capil-
lary DNA analyzer (Hitachi AB model 3730) along with
Genescan1000-ROX standard (Applied Biosystems; City of
Hope Sequencing Core). To identify the DNA amplicons,
the rest of PCR products were separated in agarose gels,
and major DNA bands were excised and cloned into dT-
tailed pCR2.1 (Invitrogen) and sequenced. Cloning total
PCR products without gel separation only yielded one
new sequence. DNA sequence identiﬁed was determined by
BLAST (http://www.ncbi.nlm.nih.gov/).
The cecal content was also cultured under aerobic and
microaerobic conditions. The cecal contents were collected
individually; the volume was measured and diluted with
10 volumes of sterile phosphate-buﬀered saline (PBS). Each
sample was diluted 10,000 times the original sample volume
with PBS and then plated with the original volume on
two Luria-Bertani (LB) plates. One plate was incubated
for 24 hours in aerobic condition, the other for 6-7 days
under microaerobic conditions, both at 37
◦C[ 20]. For
microaerobic culture, plates were placed in a GasPak (Becton
Dickerson, Cockeysville, MD) with an activated Anaerocult
A insert (EM SCIENCE, Gibbstown, NJ). The assembly
was purged with CO2. After counting the colonies, up to
10 colonies from each plate were collected and DNA was
ampliﬁed using ARISA primers. The PCR products were
resolved in 1.3% agarose gels and DNA fragments were
extractedwithQiagenGelExtractionKitandsequencedwith
the ARISA primers.
2.4. Statistics. For comparing time-to-event endpoints, such
as survival time on diﬀerent diets, the results were plottedInternational Journal of Inﬂammation 3
Table 1: Diet compositions.
Contents LabDiet1 LabDiet AIN1 AIN AIN + inulin Brewer’s Yeast (BY)2
5061 5062 5% CO 10% CO 5–10% CO 1% BY 10% BY
Protein Mixed Mixed Casein Casein Casein Mixed Mixed
(%)3 (23.4) (20.5) (23.4) (17.7) (20–26.5) (17.8) (17.7)
Yeast Brewer’s Brewer’s —4 — — Brewer’s Brewer’s
(% wt) (1) (1) (1) (10)
DL-Methionine, % (0.43) (0.48) (0.3) (0.3) (0.3) (0.3) (0.3)
Fat Mixed Mixed Corn oil Corn oil Corn oil Corn oil Corn oil
(%) (5.5) (9.6) (5.0) (10.0) (5–10) (10.3) (10.7)
Sucrose, % (3.7) (0.4) (50) (39) (5.0–38.4) (38) (35)
Other CHO5 Mixed Mixed Corn5 Corn Corn Corn Corn
(%) (56) (53) (5) (15) (27.5–15.5) (15) (15)
Cellulose (ﬁber), % (5.3) (2.7) (18.4) (11.5) (13.4–6.5) (11.5) (11.5)
Kcal/g 3.3 3.8 3.1 3.8 3.1–3.8 3.8 3.8
1LabDiets contained crude ingredients and micronutrients similar to AIN-76A (http://www.testdiet.com/). Other diets were deﬁned diets containing AIN-
76A mineral and vitamin mix. All deﬁned diets contained ∼0.002% ethoxyquin as an antioxidant, and had an adequate amount (0.2%) of choline bitartrate
or choline chloride.
2Protein, carbohydrate, and fat in Brewer’s yeast are not included in other contents.
3All % content is by weight.
4A dash means not present.
5CHO means carbohydrate, and Corn means corn starch.
with Kaplan-Meier curves and analyzed with the log-rank
test. Analysis of variance (ANOVA) was used to compare
the means ± standard deviations (SDs). To compare pair-
wise diets versus a control, Dunnett’s correction was made
formultipletestingandtheDunnett-correctedP-valueswere
applied. Each ARISA data panel represents results pooled
from 6 to 21 mice analyzed individually. The electrophero-
grams were digitized, and the results for each group were
averaged using the statistical programming language R [21,
22]. The data were cleaned and passed to the Ribosort
package created for R by Scallan et al. [23]. Ribosort detects
and classiﬁes peak-generating fragments in ARISA data with
a two-pass algorithm [24]. Output from Ribosort contains
information on the ribotype (represented by a speciﬁc
size of PCR product) abundances, ribotype proportions,
and sequencer detections. A Euclidean discriminant test
was applied to the ﬁnal step in ARISA data set analysis.
Finally, a Czekanowski similarity index was run for pair-wise
comparisons from all panels in the ARISA Figures 4, 6,a n d
8. The quantitative version of the Czekanowski similarity
index is deﬁned as 2W/(A + B), where A and B are the
abundance of species in two given sample conditions and
W is the number of species shared in the two samples. A
conventionforinterpretingtheCzekanowskisimilarityindex
is as follows: index between 0.5 to 0.75 indicates similar
abundances; index between 0.25 to 0.5 indicates diﬀerent
abundances; index between 0 to 0.25 indicates very diﬀerent
abundances.
3. Results
3.1. Genetic Background and Diet Had a Profound Eﬀect
on GPx1/2-DKO Morbidity. Mouse strain background has
ab i ge ﬀect on morbidity outcome in GPx1/2-DKO mice
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Figure 1: Kaplan-Meier curves showing the eﬀect of genetic
background and diet on DKO mouse survival. All mice are on
AIN base diets. Monitored from 8 days of age, the surviving
fraction excludes dead and culled, moribund mice. The numbers in
parenthesisarethenumberofmiceineachgroup.Thedataforyeast
are pools both 1 and 10% as no diﬀerence could be distinguished.
There are log rank diﬀerences for all interstrain comparisons on
AIN diet: P<. 0001. 129 N5, yeast-supplemented AIN (AIN +
yeast) diet versus AIN; P = .0087. 129 N10, inulin-supplemented
AIN (Ain + inulin) diet versus AIN; P = .0003.
(Figure 1). As we noted before the strain diﬀerence in
survival on the conventional LabDiet, here we report the
same genetic eﬀect on mouse survival on the AIN diet.
The AIN diet, formulated to mimic LabDiet for calories,4 International Journal of Inﬂammation
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Figure 2: Eﬀect of diet on ileum and colon histology at weaning and peak pathology by strain in GPx1/2-DKO mice. Mice on LabDiet or
AIN diet were analyzed at 22 days of age or upon signs of morbidity, and at the peak of ileitis, which is 40 days for B6;129 or 129 N5 and
50 days for B6. 129 N10 mice were only analyzed at 22 days of age due to high morbidity. The AIN diet alleviated ileitis signiﬁcantly in all
strains at both 22 days of age and at peak inﬂammation (the “∗” sign indicates P<. 011). The ileal inﬂammation/pathology scores increased
signiﬁcantly from 22 days to peak of inﬂammation in all strains ( #P <. 034). A diet-associated diﬀerence in colitis was only observed in
22-day-old 129 N10 pups (
∗P <. 001).
macro- and micronutrients, maintained better health than
LabDiets for the DKO mice.
B6 GPx1/2-DKO mice maintained fairly good health on
either a LabDiet or AIN diet. The surviving fraction of B6
DKO mice at 45 days on the AIN is 100%, which is virtually
the same as mice on LabDiet with 98% survival compared at
45 days of age (Figure 1 and data not shown). The B6;129
mixed-strain DKO mice had marginal health, with 97%
survival on AIN diet compared to 85% on LabDiet at 45
days of age. As expected, the 129DKO mice had poor health.
Eighty-ﬁve % of 129 N5 DKO on AIN diet survived 40 days
when only 65% survived on LabDiet. Only 47% of 129 N10
on AIN diet survived 40 days when merely 5% of 129 N10 on
L a b D i e tm a d ei t( P<. 0001, Log rank; diﬀerences for strains
between AIN diet and LabDiet, except B6).
For 129DKO mice, the early morbidity is associated with
colitis. The postweaning morbidity in B6 and B6;129DKO
mice is correlated with later developing ileitis and rarely
involves diarrhea. Disease in the 129 N5 and N10 DKO starts
before weaning based on symptoms of wet tail and runting
a se a r l ya s1 1d a y so fa g eo nA I Nd i e t .
3.2. Morbidity of GPx1/2-DKO Mice Is Correlated with
Gut Inﬂammation. Morbidity at any time appears to be
reﬂection of acute inﬂammation, reﬂected in the inﬂamma-
tion/pathology scores of 6 or greater [18]. B6 DKO mice
had mean ileal pathology score around 5.5 at 50 days of
age, the peak of inﬂammation in this strain (Figure 2). 129
N10 DKO mice had mean ileal and colonic pathology scores
of 6.5 and 9, respectively, at 22 days of age. The pathology
scores correlate with morbidity. Typical histopathology in
129 at 22 days of age showed acute inﬂammation in the
cecum and distal colon with frequent skipping or less severe
inﬂammation in the proximal colon (Figure 3). In morbid
mice, disease often extended into the proximal colon. By
contrast, B6 mice had almost no pathology in the cecum,
proximal, and distal colon.
Diet signiﬁcantly modiﬁed ileitis severity in all genetic
backgrounds, that is, B6, B6;129, as well as 129 N5 and
N10 DKO mice (Figure 2). Only in 129 strains was a dietary
eﬀect on colitis observed. Non-DKO mice did not have gut
pathology.
3.3. Yeast and Inulin Supplementations to AIN Diet Increased
Morbidity on 129 N5 and N10 DKO Mice. Since LabDiet has
1% brewer’s yeast, and yeast antigens are associated with
some CD, we tested its eﬀect in 129 N5 DKO mice [25].
Feeding 129 N5 DKO mice with AIN diet supplementedInternational Journal of Inﬂammation 5
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Figure 3: Representative histopathology in the colon of 129 N10 and B6 mice on AIN at 22 days of age. Slides were stained with hematoxylin
and eosin. By 22 days of age, 90% of 129 N10 DKO mice have disease signs of diarrhea and many are lethargic. B6 DKO mice are without
these signs. This is correlated with histopathology in the cecum and colons of these mice. 129 mice show inﬂammation and distortion of
the cecum and distal colon with frequent crypt abscesses in the distal colon. The inﬂammation frequently skips the proximal colon (shown
here). In severe cases, where lethargy has progressed to wasting, the proximal colon can be involved. The cecum and colon of B6 mice show
mucin depletion and mild distortion due to apoptosis and proliferation.
with 1% and 10% brewer’s yeast increased their morbidity
(P = .0087)(Figure 1 shows pooled, no diﬀerence 1% versus
10%). The morbidity curve on yeast-containing AIN diet
resembles that obtained with LabDiet (data not shown).
Although the pups experienced more pronounced diarrhea,
the pathology score was not elevated in the N5 DKO mice
on the yeast-containing diet. The median colon pathology
score was 3 at 22 days of age on both diets (P = .58), and 4.5
versus 4 for mice on yeast-containing AIN versus AIN diets
at 40 days of age (P = .9; Mann-Whitney test). Thus, yeast-
supplementation had an adverse eﬀect on the DKO mice by
increasing morbidity through intensifying diarrhea without
exacerbating colitis.
Inulin, a nondigestible fructooligosaccharide is a food
ﬁber with prebiotic properties, which may have prophylactic
or therapeutic potential for IBD [1, 26]. We supplemented
5% inulin in AIN diet to 129 N10 DKO mice on the premise
that it may retard the morbidity by fostering the colonization
of probiotic microﬂora. Disappointedly, supplementing 5%
inulin to AIN diet increased morbidity in 129DKO pups
(Figure 1; P = .0003). However, inulin did not aﬀect colon
inﬂammation; both diets yielded a median disease score of
7, P = .28 (Mann-Whitney test). Thus, inulin also had an
adverse eﬀect on DKO mice by increasing morbidity without
aﬀecting colitis.
3.4. Diet Modiﬁed Cecal Microbiota Content in Wild-Type
(WT) B6 but Not DKO Mice. Since diet can alter gut
microﬂora[16],andmicroﬂoraareessentialforIBD,weused
ARISA to proﬁle microbiota in these mice. We chose cecal
contenttoanalyzemicrobiotaforthefollowingreasons.First,6 International Journal of Inﬂammation
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Figure 4: ARISA analysis of DNA from cecal contents of B6 on
LabDiet or AIN diet. DNA ampliﬁed using primers corresponding
to 16S and 23S ribosomal genes and oriented to contain the
ribosomal intergenic spacer regions was resolved with a capillary
DNA analyzer. The x-axis shows the size of the DNA peak, and y-
axis shows the relative intensity of each peak. Each panel represents
the average result of 6 mice.
the cecum is a disease site in GPx1/2-DKO mice. Severity
of typhlocolitis is correlated with colitis in the 129 strain
(R2 = 0.63). Although the cecum has milder pathology
than the colon (with the median disease score of 6 in the
cecum and 8 in the colon of 129 N10 DKO, pooling AIN
and LabDiet scores), the cecum was the major disease site
in about 15% of mice. Second, unlike the colon, the cecum is
rarely empty even in very sick mice. Third, little variability
of microbiota is detected from six major subdivisions of
healthy human colon: cecum, ascending colon, transverse
colon, descending colon, sigmoid colon, rectum, and feces
from the same person [5].
The microbiota proﬁles on B6 DKO and WT mice were
determined individually on either LabDiet or AIN diet, and
a combined proﬁle was generated for each group of six
mice by the Ribosort package programs (Figure 4). Each
electropherogram was checked against the combined panel
to conﬁrm that the dominant DNA ribotypes in the panel
were a consensus feature of the group. We used Czekanowski
similarity index to compare the ribotype proﬁles between
diﬀerent mouse groups (Figure 5). This index is based on
both presence and abundance of ribotypes without the bias
of focusing on dominant ribotypes. Similar proﬁles were
found in B6 DKO mice on either AIN or LabDiet and B6
WT mice on the AIN diet. B6 WT on LabDiet had the
most distinct ribotype proﬁle with dramatically diminished
PCR products of 385–390bp, which were prominent in the
other 3 groups. The 385–390bp products were sequenced
and identiﬁed as either Lactobacillus species or Bacteroides
sp.( Table 2). This result supports the notion that DKO mice
have diminished diversity and thus more resistant to diet-
associated alteration of microbiota.
3.5. Genetic Background and Yeast Supplementation Had a
Dramatic Impact on Cecal Microbiota Studied in B6 and
129 N5 Groups. We then compared ARISA proﬁles in 129
N5 DKO mice and their non-DKO littermates (heterozy-
gous at Gpx1 and/or Gpx2) on LabDiet, AIN diet, or
yeast-supplemented AIN diet. Only minor diﬀerences were
detected between each group of 7–18 mice, except the DKO
mice on yeast-supplemented diet (Figure 6). Comparison by
Czekanowski similarity index of ribotype proﬁles between
diﬀerent groups of 129 N5 mice indicated the most distinct
proﬁle was produced in the yeast-supplemented DKO mice
(Figure 5). However, when comparing between B6 and 129
strains on either the same diet or the same GPx genotype,
there is a striking diﬀerence in the ribotype proﬁles.
Noticeably, the prominent 385–390bp products in B6
DKO were nearly nonexistent in the 129 N5 DKO mice on
theLabDiet.The442bpribotypewasmoreprominentin129
N5 DKO mice than their non-DKO littermates and was not
detected in B6 groups. The 129 N5 DKO mice on the yeast-
containingAINdietproducedadominantribotypeat317bp
and enhanced 385–390bp ribotypes compared to the ARISA
proﬁle of 125 N5 DKO mice on the AIN diet (Figure 6). The
317 and 385–390bp ribotypes were matched to Lactobacillus
sp.o rBacteroides sp.
3.6. Association of the 442bp DNA with Inﬂammation in the
N5129DKOMice. SincethemicrobiotaproﬁlesfromtheN5
129 strain mice were very similar, we stratiﬁed the DKO mice
into sick versus well groups, regardless of the diet (Figure 7).
Inthis comparison, the “sick” group hadfewerribotypes and
a more prominent 442 ribotype.
ToidentifytheARISADNAproducts,wehaveperformed
sequence analysis on 9 diﬀerent sizes of DNA PCR products,
whichmatchedto3bacterialphylum,Firmicutes,Bacteroides,
and Proteobacteri (Table 2). Since multiple ribosomal inter-
genic spacers exist in each bacterium, some of the PCR
products (such as the 442, 517, and 710bp) belong to the
same bacterium (Escherichia coli, Shigella,o rSalmonella)
from γ-Proterobacteri phylum. As expected, none of the
clones were matched to the mouse genome [6, 7].
3.7. Inulin Had an Opposite Eﬀect on Cecal Microbiota in 129
N10 DKO and Non-DKO Control Mice. The ARISA proﬁlesInternational Journal of Inﬂammation 7
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Figure 5: Heat map of Czekanowski similarity indexes of the ARISA proﬁles from Figures 4, 6,a n d8. An index of 0.6 (white) is moderate
similarity and an index of 0 (dark orange) is most distinct. “Cont” means the non-DKO sibs control of 129DKO mice.
of the cecal bacterial content from the inulin-supplemented
129 N10 DKO showed increase of 12 ribotypes (240, 246,
270, 290, 295, 421, 425, 540, 542, 645, 650, 652–655bp)
(Figure 8). However, the prominent putative E. coli ribotype,
442bp, in the AIN-fed DKO mice remained predominant.
In the control non-DKO (with at least one WT allele for
both GPx1 and GPx2 genes) mice, inulin supplementation
caused reduction of many ribotypes. Czekanowski similarity
index shows that the diversity of microbiota in inulin-
supplemented 129 N10 DKO is most diﬀe r e n tf r o mt h a ti n
129 N10 control non-DKO mice on AIN diet (Figure 5).
Unexpectedly, the inulin-fed 129 N10 control mice had
similar microbiota as 129 N10 DKO mice on the AIN diet.
Comparison of Czekanowski similarity index between
129 N10 groups with 129 N5 and B6 groups shows that
the 129 N10 had a more diﬀerent microbiota proﬁle from
B6 groups than 129 N5 groups (Figure 5). Yeast-fed 129 N5
DKO mice had distinct microbiota from other groups. 129
N10 DKO on AIN diet had a similar and simpliﬁed ribotype
proﬁle as 129 N5 DKO on either LabDiet or AIN diet. The
more diversiﬁed ribotype proﬁles present in 129 N10 non-
DKO control mice on the AIN diet and 129 N10 DKO on
inulin-AIN were also more distinct from those in 129 N5
groups.
3.8. Overgrowth of E. coli in the Cecum of 129DKO Mice
but Not 129 Non-DKO and B6 DKO or WT Mice. We
cultured cecal contents under aerobic and microaerobic
conditions to verify the identity of ribotypes obtained from
the noncultured method and to estimate levels of E. coli.
The putative E. coli colonies were identiﬁed by PCR with
the ARISA primers, resolving of the dominant 442 and
517bp products in agarose gels, and BLAST alignment of the
sequences obtained from the PCR products. When the PCR
was performed side-by-side with DH5α, a bioengineered
strain of E. coli, the same products were obtained, conﬁrmed
by sizing and sequencing (data not shown). These colonies
were identiﬁed as E. coli by the Microbiology Laboratory at
City of Hope. Thus, the 442bp PCR product is most likely
indicative of E. coli.
The prediction that the 129 N10 DKO mice would show
overgrowth of E. coli was substantiated by counts of cultures
from cecal contents on LB plates (Figure 9). E. coli was
detected in 28 of 31 mice on AIN diet at an average of ∼1
× 109 CFU/g cecal contents. On LabDiet, 6 of 6DKO mice
had detectable E. coli at an average ∼1.5 × 109 CFU/g. WT
mice had average E. coli levels of ∼1 × 106 CFU/g, detected
in 3 of 12 mice on AIN diet, which are at the lower limit of
detection.
The 129 N5 cohort was not available for these follow-
up studies; so their descendents at N7 were studied. E. coli
colonies were isolated from 129 N7 DKO on either LabDiet
(2 of 2 mice) or AIN diet (3 of 8 mice) cultured under
both aerobic and microaerobic conditions at an average8 International Journal of Inﬂammation
Table 2: Identiﬁcation of ARISA peak DNA.
Base pair Top BLAST hits of ARISA peak DNA1 Phylum Matched from bacterial culture2
2931 Lactobacillus animalis/murinus Firmicutes Lactobacillus sp.3
300 Firmicutes Enterococcus gallinarum
3171 Lactobacillus animalis/murinus Firmicutes
350 Firmicutes Enterococcus faecalis
380 Firmicutes Staphylococcus hemolyt./saprophy.
385–3901,3 Lactobacillus sp. Firmicutes Lactobacillus sp.3
Uncultured bacteria CD4 Bacteroides sp.
400 Firmicutes Staphylococcus simulins
4211 Bacteroides sp. Bacteroidetes
Uncultured bacteria CD4 Bacteroides sp.
4421 Escherichia coli, Shigella, Salmonella γ-Proteobacteri E. coli3
480 Firmicutes Lactobacillus sp.3
5171 E. coli, Shigella, Salmonella γ-Proteobacteri E. coli3
Uncultured bacteria CD4 Bacteroides sp.
5861 Dysgonomonas wimpennyi Bacteroidetes
7101 E. coli APEC, Shigella, Salmonella γ-Proteobacteria
7921 Helicobacter ganmani ε-Proteobacteria
800 Actinobacteria Biﬁdobacterium sp.
1Eight prominent ARISA peak DNAs plus the 710 bp DNAs were cloned into plasmid and sequenced. The identity of the ARISA fragments was determined
using a Basic Local Alignment Search Tool (BLAST; http://www.ncbi.nih.gov/).
2The ARISA peak DNA size was matched to the PCR product of cultured bacterial DNA from mouse cecal content using the same primers.
3DuetotheclusteringofDNAproductsinthe385–390bpandlimitationofthecloning/sequencingvector,thespeciﬁcsizeoftheclonescannotbedetermined.
Because multiple ribosomal intergenic spacers exist in each bacterium, single E. coli colonies produced amplicons at ∼442, ∼517, and ∼710 bp and single
colonies of Lactobacillus produced amplicons at ∼293, 385–390, and ∼480 bp.
4DNA sequences obtained from at least one clone each of ARISA DNA at 385–390, 421, and 517bp were matched to an uncultured bacteria CD,
LMOACA3ZDO3RM1 clone, submitted by Manichanh et al. obtained from the fecal sample of a Crohn’s disease patient [27].
∼2 × 108 CFU/g. No putative E. coli colonies were obtained
from 129 N7 non-DKO mice (0 of 7 mice). These include
2non-DKOsiblingsonLabDietand5non-DKO129miceon
AIN diet under either aerobic or microaerobic conditions.
Several other species of commensal bacteria were also
isolated from 129 N7-N10 DKO mice. Under aerobic
condition, Staphylococcus and Enterococcus sp. were cultured
from two 129 N7 DKO mice (one well, one sick) on the
AIN diet. No E. coli was detected in these two 129DKO
mice. The anaerobic plates from 5 of 8 129 samples yielded
Lactobacillus, which also matched to a rat gut-uncultured
bacterium, DR6-87 [28].
No E. coli was isolated from B6 DKO (n = 5) or WT
mice (n = 7) on the AIN diet. On the LabDiet, E. coli was
detected in 3 of 14 B6 DKO mice at an average level of
∼2 × 107 CFU/g. Under aerobic conditions, Staphylococcus
was identiﬁed from 2 B6 DKO mice on the LabDiet and
Enterococcushiraefrom1mouseontheLabDiet.However,all
mice produced Lactobacillus sp. (DR6-87) on microaerobic
plates. E. faecalis and Biﬁdobacterium were isolated from
one DKO mouse each on the LabDiet and the AIN diet,
respectively.
4. Discussion
The genetic background of GPx1/2-DKO mice is known to
have a strong inﬂuence on disease course. Here, we show
that the genetic background also has a strong impact on
cecal microbiota. In fact, the genetic background of the
inbred mice has the strongest impact on the gut microbiota
compared to diet and GPx genotype. Since the mouse
colonies were housed on the same cage rack, it is unlikely
that the diﬀerent microbiota come from physical separation.
Since B6 and 129 strains may have diﬀerent innate immune
responses, which can modulate microﬂora community [2,
13], our result provides an evidence to support the notion
t h a th o s tg e n e t i c sc a na ﬀect gut microbiota. A strong
genetic eﬀect on microﬂora has been observed in humans
from studies of monozygotic and dizygotic twins versus
cohabitating, unrelated individuals [29–31].
Since Paneth cells in the mouse ileum express mul-
tiple genes encoding for antimicrobial peptides includ-
ing α-defensin-related cryptidins and the mouse-speciﬁc
cryptidin-relatedsequences(Defcr-rs)[32],itispossiblethat
the quantity and/or types of antimicrobial peptides aﬀect
gut microbiota composition (our unpublished observation
from Agilent 44K Mouse Expression Array analysis). The
Defcr-rs gene subfamily that codes for several cysteine-rich-
sequence-4C (CRS4C) peptides is unique to mice and these
CRS4C peptides also have bactericidal activity [32]. We have
found that 129 strain mice have elevated Defcr-rs2 (encoding
for CRS4C-1),- r s 1 0(CRS4C-4) and -rs12 (CRS3C-5) gene
expression in the ileum of both DKO and WT mice, when B6
has low or undetectable expression of these genes. Shanahan
et al. reported that Defcr-rs2 and -rs10 genes were highly
expressed in SAMP1/YitFc mice (which had spontaneousInternational Journal of Inﬂammation 9
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Figure 6: ARISA analysis of DNA from cecal contents of 129 N5.
This DKO colony was established by backcrossing the mixed strain
B6;129colonyto129Sv/Jfor5generations.Theplotsweregenerated
from 15DKO mice on AIN diet (AINDKO), 18 DKO mice on
LabDiet (LabDietDKO), 7DKO mice on AIN diet supplemented
with 1% yeast (Yeast DKO), 13 non-DKO mice on AIN diet (AIN
non-DKO), and 13 non-DKO mice on LabDiet (LabDiet non-
DKO). Non-DKO mice were the sibs of DKO mice, heterozygous
for Gpx1 and/or Gpx2 (thus no inﬂammation). DKO mice on
LabDiet did not have the distinctive peaks at 385–390bp, 421bp,
481bp, and 498bp found in other groups. DKO mice on the yeast-
containing diet had a similar proﬁle as AIN-fed mice, except having
a prominent 317bp peak. The 442bp ribotype found in these 129
N5 DKO mice had lower abundance in the non-DKO sibs on both
LabDiet and AIN diets.
ileitis) and barely detectable in B6 strain. Since both 129
strain mice and SAMP1/YitFc mice with high expression of
some of the Defcr-rs genes are prone to inﬂammation, it
was postulated that the cysteine-rich CRS4C peptides may
also aﬀect cellular homeostasis such as aﬀecting autophagy,
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Figure 7: ARISA analysis of DNA from cecal contents of 129
N5 DKO mice stratiﬁed by the disease severity. Seven of 18DKO
mice on LabDiet, 13 of 14DKO mice on AIN diet, and 9 of
16DKO mice on AIN diet with daily contact of soiled bedding from
LabDiet group were combined in the well group (29 mice) based on
pathology. The other 19DKO mice were stratiﬁed in the sick group.
The median colon pathology score for well mice was 3 (range of
0–5) and 6 for sick mice (range of 6–11).
unfolded protein response, and apoptosis. Because of the
complex nature of the defensin gene family in mice, we plan
toexplorethisissuefurtherandpresentitinacomprehensive
manner in the future.
Although the ARISA proﬁle has limited resolution, we
were able to identify 9 species that belong to 3 bacteria
phyla, Firmicutes, Bacteroides,a n dProteobacteri, commonly
present in human gut. From our small list of bacteria, we
have identiﬁed E. coli as a potential harmful bacteria species,
where overgrowth is associated with 129 but not B6 mice.
With the ARISA primers, E. coli produces a 442bp PCR
product, which is present in the 129 strain and absent
in B6 mice. In the 129 strain, this 442bp ribotype is
more abundant in the DKO than that control non-DKO
mice, with the only exception of inulin-fed non-DKO mice.
Furthermore, this 442bp PCR product is more prominent
in the sick than well 129 N5 DKO mice. Although the
442bp ribotype is also matched to Shigella and Salmonella
in the Proteobacteri bacteria phyla by sequence analysis,
our isolation of E. coli species from several 129 DKO mice
supportstheE.coliidentityofthis442bpDNAPCRproduct.
The sick 129 DKO mice also have a more prominent 517bp
DNA also produced by our cultured putative E. coli clones as
well as from a laboratory strain of E. coli, DH5α.D e t e c t i o n
of the 442bp but not the 517bp PCR products may be
because the larger product is not as eﬃciently ampliﬁed as
the shorter one when E. coli DNA is present in a mixture of
other bacteria DNA. The results shown in the ARISA panels
coupled with counts from diluted cecal contents on LB plates
suggest that detection of the 442bp ribotype peak required
1 × 108-1 × 109 CFU/g. Since most of the well mice, B6 or
129,havecountslessthan2×107 CFU/g,thecountsobtained
for sick 129DKO mice appear to represent an overgrowth of10 International Journal of Inﬂammation
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Figure 8: ARISA analysis of DNA from cecal contents of 129
N10. This DKO colony was established by backcrossing the mixed
strain B6;129 colony to 129Sv/J for 10 generations. The group
sizes are 21DKO mice on AIN diet, 10 non-DKO mice on inulin-
supplementedAINdiet,7non-DKOmiceonAINdiet,and15DKO
mice on inulin-supplemented AIN diet. The non-DKO mice are
heterozygous DKO with 2 or 3 WT alleles for combined Gpx1 and
Gpx2.
E. coli. Enteropathic E. coli has been linked to Crohn’s disease
and Salmonella to enterocolitis by opportunistic invasion
of inﬂamed areas [7, 33–37]. These bacteria may create
the opportunity for overcoming colonization resistance by
eliciting an inﬂammatory response and then invading the
inﬂamed region [37].
The DKO mice are more resistant to dietary impact
on microbiota proﬁles than control mice. This result is
consistent with the notion that inﬂammation in DKO mice
diminishes bacteria diversiﬁcation relative to that in the
control mice, which was reported in human IBD patients
[3, 4]. The limitations on bacterial diversity in DKO mice
can explain why diet alters ARISA proﬁles only in B6 WT but
not in B6 DKO mice. Although 129 N5 mice on either AIN
or LabDiet have rather similar proﬁles, DKO mice on these
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Figure 9: Box and whisker plots of the levels of cecal E. coli (large
coloniesonLBplatesunderaerobicconditions)andEnterococcus sp.
(small colonies on LB plates; E. faecalis, E. hirae, or E. gallinarum)
for mice on AIN diet. Bacteria counts are based on colony forming
units per gram of cecal contents (CFU/g) at 24 hours, 37
◦C.
Representative colonies were stabbed with a micropipet tip and
transferred to ARISA PCR mix. The PCR products were resolved
on agarose gels for comparison to laboratory E. coli and the PCR
productswerefurtherisolatedandsequencedforﬁnalidentiﬁcation
of species.
two diets have higher similarity index than non-DKO mice
on these two diets. Non-DKO mice were used because they
were littermates of DKO mice, thus shared the same bedding
but did not have gut pathology.
Supplementation of yeast to the AIN diet changed
bacteria proﬁle dramatically in 129 N5 DKO mice. Yeast pro-
duced a prominent 317bp ribotype matched to Lactobacillus
animalis or L. murinus in Firmicutes phylum. Although the
Lactobacillus sp. have been used as probiotics, they can also
induce reactive oxygen species (ROS) from macrophages
[38]. This pro-oxidant property of these bacteria may blunt
their probiotic activity in the DKO mice. This may explain
why the yeast-AIN diet increased morbidity and diarrhea,
but not colon inﬂammation, in 129 N5 DKO mice. It is
unclear why the LabDiet (which has 1% brewer’s yeast)
did not produce this 317bp ribotype in both 129 N5
DKO and non-DKO mice. Perhaps other ingredients in the
LabDiet have masked or countered the eﬀect of yeast. IBD
patients tend to have high antibody titers against yeast [39],
and mannan-containing yeast-wall components are strong
activators for macrophages and neutrophils [40]. However,
our result does not support the proinﬂammatory activity of
yeast.
Inulin is a prebiotic, which has been used to manage IBD
bychanginggutmicrobiota[1,26].Dietarysupplementation
of inulin increases the number of Biﬁdobacteria in humans
and animals [41, 42]. Interestingly, supplementing inulin
to AIN diet has an opposing eﬀect on microﬂora between
129 N10 DKO and control mice. Inulin increases bacteria
diversity in DKO but decreases diversity in control mice.
Consequently, the diverse ARISA proﬁles are more distinct
from each other, when the converged proﬁles become
similar. Most disappointedly, inulin did not eliminate the
442bp, likely from E. coli colonization. This may explain
the lack of anti-inﬂammatory activity of inulin in 129DKO
mice.International Journal of Inﬂammation 11
The impact of the GPx1/2-DKO construct on microbial
diversity is likely due to increases in reactive oxygen species
and activation of innate immune response. We have shown
that the DKO intestine has higher levels of lipid peroxidation
and myeloperoxidase/lactoperoxidase activity compared to
non-DKO control mice [10]. This increased oxidative stress
may explain the elevated apoptotic cell death in the crypt
epithelium accompanied by degranulation of Paneth cells
and mucin depletion [11]. The primary function of enteric
defensins is thought to be a regulatorof intestinal microbiota
[43]. Mucin excretion can inhibit bacterial adhesion [44].
Conceivably, overexpression or depletion of these antimicro-
bial molecules can alter luminal microﬂora.
5. Conclusions
In summary, using a nonculture ARISA we examined the
eﬀect of mouse strain background, diet and DKO genotype
on the gut microbiota. We found that B6 versus 129 strain
backgroundhasthegreatestoverallimpactonthemicrobiota
with similarity indexes from 0.26 to 0.12 when matched for
diet and GPx status. GPx status did not aﬀect the strain-
based dissimilarity. In comparing AIN and LabDiet, DKO
mice were more resistant to change than the non-DKO
or WT mice in both B6 and 129 strains. This may be
due to inﬂammation in the DKO gut, which has restricted
microﬂora diversity. However, supplementing yeast and
inulin to AIN diet greatly altered microﬂora proﬁles in the
DKO mice. We have identiﬁed a 442bp DNA from E. coli,a s
a proinﬂammatory bacteria associated with 129 strain mice
especially with the DKO genotype.
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